Human Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells
Citations Over TimeTop 1% of 2016 papers
Abstract
In the pancreatic islet, serotonin is an autocrine signal increasing beta cell mass during metabolic challenges such as those associated with pregnancy or high-fat diet. It is still unclear whether serotonin is relevant for regular islet physiology and hormone secretion. Here, we show that human beta cells produce and secrete serotonin when stimulated with increases in glucose concentration. Serotonin secretion from beta cells decreases cyclic AMP (cAMP) levels in neighboring alpha cells via 5-HT1F receptors and inhibits glucagon secretion. Without serotonergic input, alpha cells lose their ability to regulate glucagon secretion in response to changes in glucose concentration, suggesting that diminished serotonergic control of alpha cells can cause glucose blindness and the uncontrolled glucagon secretion associated with diabetes. Supporting this model, pharmacological activation of 5-HT1F receptors reduces glucagon secretion and has hypoglycemic effects in diabetic mice. Thus, modulation of serotonin signaling in the islet represents a drug intervention opportunity.
Related Papers
- → Studies of pancreatic alpha cell function in normal and diabetic subjects(1970)836 cited
- → Development of a glucagon sensitivity test in humans: Pilot data and the GLUSENTIC study protocol(2022)10 cited
- → Advances in basic research on glucagon and alpha cells(2024)2 cited
- → 1192-P: Robust Arginine-Stimulated Glucagon Secretion in Patients with Type 1 Diabetes Independent of Diabetes Duration, Age, HbA1c, and Beta-Cell Secretory Capacity(2021)
- → Glucagon in Islet and Metabolic Regulation(2024)